DXCM gains from CGM demand, Medicare coverage expansion and its new G7 15-day sensor, but rising competition and ...
New Ontario Drug Benefit (ODB) coverage means eligible Ontarians who take insulin can now benefit from using Dexcom G7 to simplify management of their diabetes. Ontario residents eligible for ODB and ...
DexCom, Inc. DXCM reported third-quarter 2025 adjusted earnings per share (EPS) of 61 cents, which beat the Zacks Consensus Estimate of 57 cents by 7%. The company reported earnings of 45 cents per ...
DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets CGM systems to help individuals with types 1 and 2 diabetes monitor and control their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results